首页 | 本学科首页   官方微博 | 高级检索  
检索        


Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists,the International Association for the Study of Lung Cancer,and the Association for Molecular Pathology
Authors:Neal I Lindeman  Philip T Cagle  Dara L Aisner  Maria E Arcila  Mary Beth Beasley  Eric H Bernicker  Carol Colasacco  Sanja Dacic  Fred R Hirsch  Keith Kerr  David J Kwiatkowski  Marc Ladanyi  Jan A Nowak  Lynette Sholl  Robyn Temple-Smolkin  Benjamin Solomon  Lesley H Souter  Erik Thunnissen  Yasushi Yatabe
Institution:1. Department of Pathology, Brigham and Women''s Hospital, Boston, Massachusetts;9. Department of Medicine, Brigham and Women''s Hospital, Boston, Massachusetts;2. Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas;3. Department of Pathology, University of Colorado School of Medicine, Denver, Colorado;4. Diagnostic and Molecular Pathology Laboratory, Memorial Sloan Kettering Cancer Center, New York, New York;10. Molecular Diagnostics Service, Memorial Sloan Kettering Cancer Center, New York, New York;5. Department of Pathology & Medicine, Pulmonary, Critical Care and Sleep Medicine, New York, New York;6. Cancer Research Program, Houston Methodist Research Institute, Houston, Texas;7. Pathology and Laboratory Quality Center, College of American Pathologists, Northfield, Illinois;11. Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania;12. Department of Medicine and Pathology, University of Colorado, Denver, Colorado;8. Department of Pathology, University of Aberdeen, Aberdeen, Scotland;71. Department of Molecular Pathology, Roswell Park Cancer Institute, Buffalo, New York;112. Clinical and Scientific Affairs Division, Association for Molecular Pathology, Bethesda, Maryland;123. Molecular Therapeutics and Biomarkers Laboratory, Peter Maccallum Cancer Center, Melbourne, Australia;84. Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands;95. Department of Laboratory Medicine and Pathobiology, Princess Margaret Cancer Center, Toronto, Ontario, Canada;106. Scientific Affairs, International Association for the Study of Lung Cancer, Aurora, Colorado;77. Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan
Abstract:
Keywords:Address correspondence to: Neal I  Lindeman  M  D    Brigham and Women's Hospital  Department of Pathology  75 Francis St    Shapiro 5  Room 020  Boston  MA 02115  
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号